The disease is self-limiting and the virulent inflammation usually subsides in about 10 days.
According to Duke-Elder (1938) corneal involvement takes three forms (i) marginal infiltration of the cornea which becomes vascularized and clears up.
(ii) true vaccinal pustule, commencing after an incubation of one to five days, with ulcer formation. This is a serious affair and follows a long and painful course.
(iii) disciform keratitis, which, after a slow course, may clear up entirely. Atkinson and Scullard (1940) 
Discussion
It is dangerous to draw conclusions from a single case, especially in a disease self-limiting by nature. The question to be decided is twofold:
(1) has any treatment influenced the course of the disease, or is it in fact a natural cure; (2) if the treatment was of material benefit, to which of the therapeutic agents used is this benefit to be ascribed.
With regard to the first point, the length of time which the acute stage lasted may suggest that the evidence is inconclusive. It may be pointed out, however, that the infection was severe, and serious doubts were entertained at one time regarding the fate of the eye. Furthermore, the patient having last been vaccinated 15 years previously, no increase in general immunity was to be expected from this source, as in cases of auto-inoculation. It might be presumed, therefore, that the disease would run its full course. Perhaps the significant feature of this case is that when immune serum was given on two occasions a striking improvement occurred in the clinical condition. The first, which consisted of 30 ml. serum given in two doses intramuscularly, produced immediate improvement in the condition of the conjunctival sac, although it failed to prevent a moderately severe infection of the cornea. The second, consisting of immune serum drops, with 10 ml. immune serum intramuscularly, produced an immediate improvement in the corneal condition. It is known that virus infections of the cornea may run a prolonged course, and apparently vaccinia is no exception. In this case, not only did the corneal lesions clear up relatively soon, but there has so far been no further trouble, over a year after the infection was contracted.
As regards the other therapeutic agents, vitamin C, potassium permanganate solutions, and aureomycin, the disease progressed in spite of their exhibition. Recently King and Robie (1951) have reported good results from aureomycin, and it is possible that aureomycin by mouth might have had more effect in this case.
It is suggested that there is primafacie evidence of benefit obtained from the use of specific immune serum. It is important to give the serum in the form of drops locally, to prevent corneal infection, as well as intramuscularly, to benefit the conjunctival condition. 
